• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.13%

    Clovis Oncology, Inc. (CLVS)

    -NasdaqGS
    82.81 Down 4.19(4.82%) Jun 2, 4:00PM EDT
    |After Hours : 83.50 Up 0.69 (0.83%) Jun 2, 6:04PM EDT
    Add to Portfolio
    Prev Close:87.00
    Open:86.53
    Bid:82.55 x 100
    Ask:102.99 x 100
    1y Target Est:106.00
    Beta:1.37
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:82.52 - 86.90
    52wk Range:35.33 - 102.28
    Volume:1,065,377
    Avg Vol (3m):762,958
    Market Cap:2.82B
    P/E (ttm):N/A
    EPS (ttm):-5.67
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Headlines

    » More Headlines for CLVS

    Comparison

    Symbol% ChgMkt Cap
    CLVSDown 4.82%2.82B
    IMMUUp 1.52%374.79M
    LRUSF 0.00%N/A
    THLDDown 1.82%268.93M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-8.61
    Quarterly EPS Est (Jun-15) :-2.01
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback